Start-Up Previews, October 2014
Executive Summary
This month’s profile group, Antibiotics: Officially Encouraged, Increasingly Precise, Still Risky, features profiles of EnBiotix, Nosopharm, and Spero Therapeutics. Plus these Start-Ups Across Health Care: Elute, Madison Vaccines, Monarch Medical Technologies, Niveus Medical, and SolaranRx.
You may also be interested in...
Monarch Medical Technologies Inc.
When it comes to effective blood glucose management, the difference is in the math, says Monarch Medical Technologies Inc. The company makes the EndoTool IV glucose management system, a patient-specific, glycemic-control computer software tool that provides individualized insulin dosing.
Elute Inc.
Elute Inc. is developing an antibiotic-releasing bone void filler designed to reduce the incidence of surgical site infections from primary and revised orthopedic procedures.
Niveus Medical Inc.
The Muscle Stimulation System 110 from Niveus Medical Inc. combines electricity with localized cooling to help prevent atrophy and associated deconditioning in hospital patients facing extended periods of bed rest.